Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda
A Randomized Trial of the Acceptability and Safety of Early Infant Male Circumcision (EIMC) Conducted by Nurse Midwives and Clinical Offices Using the Mogen Clamp
1 other identifier
interventional
501
0 countries
N/A
Brief Summary
Background: Medical male circumcision (MMC) for HIV prevention is a priority in 14 East and Southern African countries, and the long-term sustainability of MMC programs could best be achieved by early infant male circumcision (EIMC.) However, the acceptability and safety of EIMC provided by non-physicians is unknown. Methods: We conducted a trial of EIMC using the Mogen clamp provided by newly trained clinical officers (CO) and nurse midwives (NMWs) in 4 health centers in rural Rakai, Uganda. 501 healthy neonates aged 1-28 days with normal birth weight and gestational age were randomized to CO (n=256) and NMWs (n=245), and were followed up at 24 hours, 7 and 28 days. Combined analgesia was provided by paracetamol suppository, Eutectic Mixture of Local Anesthetics (EMLA) cream and a 24% sucrose solution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 2014
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 23, 2015
CompletedFirst Posted
Study publicly available on registry
November 4, 2015
CompletedNovember 4, 2015
November 1, 2015
9 months
October 23, 2015
November 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Adverse events related to circumcision
Adverse events graded as mild, moderate and severe
4 weeks
Acceptability as measured by the proportion of mothers directly informed about the study who consented to enroll in the trial
Proportion of registered mother-child pairs in which the male infant was circumcised
through study completion, an of 1 year
Wound healing
Completed wound healing (clean intact scar without a scab or stitch sinus)
4 weeks
Secondary Outcomes (3)
Procedure time
Less than 15 minutes
Parental satisfaction
4 weeks
Neonatal pain scale (NIPS)
During surgery
Study Arms (2)
Clinical Officer (CO),
ACTIVE COMPARATORCOs were trained and provided neonatal male circumcision under topical anesthesia using the Mogen clamp
Nurse Midwife (NMW)
EXPERIMENTALNMWs were trained and provided neonatal male circumcision under topical anesthesia using the Mogen clamp
Interventions
The standard procedure for neonatal circumcision is as follows: combined analgesia was topical 2.5% lidocaine and 2.5% prilocaine \<1 gm applied 60 minutes and 40mg acetaminophen suppository 30 minutes prior to surgery. Infants were given a 24% sucrose solution pacifier if needed. Infants under 2 weeks of age received subcutaneous Vitamin K 1 mg. The perineum cleaned, and the penis swabbed with povidone iodine. Hemostats were applied at 3 and 9 o'clock positions and the glans pushed down. Traction was applied before placing the Mogen clamp, the clamp was closed for 5 minutes and the foreskin removed with a scalpel. Petroleum jelly (e.g., Vaseline) was applied to the glans and the wound covered with sterile gauze. Infants were observed for one hour. Mothers were instructed in wound care.
Eligibility Criteria
You may qualify if:
- age 1-28 days
- birth weight \>= 2,500 gm
- gestational age \>=37 weeks
- no illness. normal temperature
- no genital anatomic abnormality
You may not qualify if:
- age \>28 days
- birth weight \<2,500 gm
- gestational age \<37 weeks
- Ill health
- genital abnormality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Kankaka EN, Murungi T, Kigozi G, Makumbi F, Nabukalu D, Watya S, Kighoma N, Nampijja R, Kayiwa D, Nalugoda F, Serwadda D, Wawer M, Gray RH. Randomised trial of early infant circumcision performed by clinical officers and registered nurse midwives using the Mogen clamp in Rakai, Uganda. BJU Int. 2017 Jan;119(1):164-170. doi: 10.1111/bju.13589. Epub 2016 Sep 6.
PMID: 27597563DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald H Gray, MD MSc
Johns Hopkins Bloomberg School of Public Health
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 23, 2015
First Posted
November 4, 2015
Study Start
October 1, 2014
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
November 4, 2015
Record last verified: 2015-11